COMMUNIQUÉS West-GlobeNewswire

-
BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures
03/09/2025 -
MATTER Launches Major Initiative to Improve Health System in Ukraine
03/09/2025 -
Carbon Capture Made Scalable: Decarbontek Debuts Breakthrough Modular Adsorbent Technology
03/09/2025 -
Instinct Science & VECCS Partner to Bring Essential Reference Plumb’s Veterinary Drugs and Standards of Care to Emergency & Critical Care Teams
03/09/2025 -
TeamACO reduces avoidable costs by $15.8M for Medicare value-based care program
03/09/2025 -
Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
03/09/2025 -
2025 Rising Stars to Take the Stage at BioNTX iC³® Life Science & Healthcare Innovation Summit
03/09/2025 -
KFSHRC Reinforces Global Leadership as Early Adopter of Advanced cell and Gene Therapies
03/09/2025 -
Scenic Biotech Publishes Novel Drug Target for Mitochondrial and Cardiac Disease in Nature
03/09/2025 -
Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results
03/09/2025 -
Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
03/09/2025 -
Invitation to Idorsia’s aprocitentan (TRYVIO/JERAYGO) investor Q&A webcast and conference call
03/09/2025 -
CareMore Health Forms Partnership with Verda Health Plan of Arizona to Bring Healthcare Services to Hispanic, Asian and Arab American Communities in Maricopa County, Arizona
03/09/2025 -
Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025
03/09/2025 -
Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting
03/09/2025 -
Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference
03/09/2025 -
Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq
03/09/2025 -
vTv Therapeutics to Participate in Upcoming September Investor Conferences
03/09/2025 -
electroCore Appoints Elena Bonfiglioli to Board of Directors
03/09/2025
Pages